- Opening Remarks
- Case Presentation and Assessment
- Guideline Recommendations for Moderate to Severe Psoriasis and PsA
- Closing Remarks and Question and Answer Session
April W. Armstrong, MD
Professor of Dermatology (Clinical Scholar)
Associate Dean for Clinical Research
Keck School of Medicine
University of Southern California
Philip J. Mease, MD
School of Medicine
University of Washington
Swedish Medical Center
Providence St Joseph Health
The goal of this activity is to improve learners’ knowledge and competence in applying current and emerging treatment strategies in the holistic management of patients with psoriasis and PsA.
This program is intended for rheumatologists, dermatologists, primary care physicians, nurse practitioners, and other healthcare professionals who care for patients with psoriatic disease.
Upon completion of this activity, participants should be able to:
- Apply guideline recommendations for psoriasis and PsA treatment selection according to disease severity, treatment history, and functional and QoL status
- Describe common comorbidities associated with psoriatic disease and strategies for identifying and managing these conditions
- Outline coordination of care with other healthcare professionals that fosters a whole-patient approach to psoriatic disease and related conditions and concerns
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Psysicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.